In an urgent move to curb a burgeoning public health crisis, the World Health Organization (WHO) has issued a stark warning regarding the meteoric rise of nicotine pouches. These discreet, flavored, and highly addictive products are flooding global markets, often outpacing the ability of national regulators to contain them. As the international community prepares for World No Tobacco Day on May 31, the WHO’s latest report, Exposing marketing tactics and strategies driving the growth of nicotine pouches, highlights a calculated industry effort to ensnare adolescents and young adults in a cycle of nicotine dependence.
Main Facts: The Anatomy of an Emerging Epidemic
Nicotine pouches are small, porous sachets typically placed between the gum and the lip. Unlike traditional cigarettes, which require combustion, or even early-generation vapes, these products offer a "clean" appearance—they are smokeless, odorless, and often marketed as a modern, lifestyle-compatible alternative to combustible tobacco.
However, the WHO emphasizes that these products are anything but harmless. They contain nicotine—a potent, highly addictive neurotoxin—alongside an array of flavorings, sweeteners, and chemical additives designed to mask the harshness of the drug and enhance its appeal.
The growth trajectory of these products is staggering. In 2024 alone, retail sales of nicotine pouches surpassed 23 billion units globally, a 50% increase from the previous year. The market, now valued at nearly US$ 7 billion as of 2025, represents a significant shift in how the tobacco and nicotine industry is diversifying its portfolio to maintain profits in an era of declining cigarette smoking.
Chronology of a Regulatory Failure
The rapid expansion of the nicotine pouch market is a case study in how innovation often outruns public policy.
- 2020–2022: The Emergence. As global smoking rates began to plateau or decline, industry giants pivoted to "reduced risk" alternatives. Nicotine pouches were introduced as a convenient, discreet option, initially targeting adult smokers looking to quit.
- 2023: The Regulatory Gap. While traditional tobacco products are strictly regulated under the WHO Framework Convention on Tobacco Control (FCTC), nicotine pouches often occupied a legal "grey zone." In many jurisdictions, they were not classified as tobacco products because they did not contain leaf tobacco, allowing them to circumvent marketing restrictions and tax laws.
- 2024: The Explosion. Marketing tactics became increasingly aggressive. The industry shifted focus from "cessation aid" to "lifestyle accessory," utilizing social media influencers and sleek packaging to capture a younger demographic.
- 2025: The Global Response. Recognizing the mounting evidence of harm and the lack of oversight, Member States requested formal guidance from the WHO. This culminated in the current global report, providing a comprehensive framework for governments to catch up to the industry’s rapid expansion.
Supporting Data: By the Numbers
The data underpinning the WHO’s warning paints a grim picture of a product engineered for addiction:
- Explosive Volume: The 50% year-over-year increase in unit sales indicates a rapid adoption rate that is difficult for health systems to track, let alone control.
- Nicotine Concentration: Some products are being marketed in tiered strengths—"beginner," "advanced," and "expert"—with nicotine content reaching as high as 150 mg per pouch. To put this in perspective, this concentration is significantly higher than what is found in a traditional cigarette, creating a potential for rapid, severe physiological dependence.
- Market Valuation: A US$ 7 billion market signifies massive capital investment. This level of funding allows companies to engage in saturation marketing, from sports sponsorships to candy-colored social media campaigns that specifically target youth.
Official Responses: The WHO Mandate
The WHO leadership has been unequivocal in its condemnation of the industry’s current strategies.
"The use of nicotine pouches is spreading rapidly, while regulation struggles to keep pace," said Dr. Vinayak Prasad, Unit Head of the Tobacco Free Initiative at the WHO. "Governments must act now with strong, evidence-based safeguards."
Dr. Etienne Krug, Director of the Department of Health Determinants, Promotion and Prevention, echoed this sentiment, emphasizing the predatory nature of the industry’s design. "These products are engineered for addiction, and there is a strong need to protect our youth from industry manipulation," Dr. Krug stated. "We are seeing the use of these products spread quickly, especially among adolescents and young people who are being aggressively targeted by deceptive tactics."
The WHO is calling for a comprehensive regulatory overhaul that treats nicotine pouches with the same—or stricter—stringency as combustible tobacco. Key recommendations include:
- Strict Marketing Bans: Eliminating the use of candy-like packaging and youth-oriented branding.
- Flavor Restrictions: Prohibiting the use of additives that make the products palatable to non-users, particularly minors.
- Mandatory Warning Labels: Standardizing health warnings to accurately communicate the cardiovascular and neurological risks.
- Age-of-Sale Laws: Implementing and enforcing strict age verification to prevent youth access.
Implications: The Long-term Health Cost
The health implications of widespread nicotine pouch use are profound, particularly regarding the developing brain.
Neurodevelopmental Impact
The human brain continues to develop well into the mid-twenties. Nicotine exposure during this critical window is known to interfere with neural pathways, affecting cognitive functions such as attention, learning, and impulse control. The WHO warns that early-onset nicotine dependence can lead to long-term cognitive deficits that may persist into adulthood.
The Gateway Effect
There is significant concern that these pouches serve as a "gateway" product. By normalizing the act of nicotine consumption in social settings, these products lower the threshold for experimentation. Once a young person is chemically dependent on nicotine, the transition to other, more harmful tobacco products becomes statistically more likely.
Cardiovascular Risks
Beyond the brain, nicotine is a known vasoconstrictor, meaning it narrows blood vessels and increases heart rate and blood pressure. Long-term use of high-concentration nicotine pouches places a sustained, significant burden on the cardiovascular system, increasing the risk of hypertension and potential heart disease later in life.
A Call for Coordinated Global Action
The WHO’s call to action is not merely a request for policy updates; it is a plea for a global, coordinated defense against a public health threat that transcends borders. The organization stresses that nicotine pouches should never be considered "risk-free," despite the industry’s efforts to rebrand them as such.
The upcoming World No Tobacco Day on May 31 will serve as a platform for this campaign. The theme, which focuses on exposing the tactics used by the industry to hook a new generation, will highlight the necessity of science-based regulation.
Governments are encouraged to look at the scientific consensus, which is clear: the industry’s growth in this sector is not driven by the need to provide harm-reduction tools for existing smokers, but by the desire to expand their consumer base to include the next generation.
Conclusion: Protecting the Future
The current trajectory of nicotine pouch consumption is a direct threat to the health and well-being of young people worldwide. As the WHO notes, the only way to prevent a new generation from falling into the trap of lifelong nicotine dependence is through immediate, robust, and transparent regulation.
By demanding that governments implement comprehensive safeguards—such as capping nicotine levels, banning youth-appealing flavors, and enforcing strict marketing controls—the international community can begin to dismantle the infrastructure of this emerging addiction epidemic. The message from the WHO is clear: the health of our youth must be prioritized over the profits of the tobacco industry. Science must be the bedrock of our policy, and the protection of the vulnerable must be the goal of our collective future.
About the Author
